This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Glen Banks: Innovator in Miniaturized Dystrophins
Introduction
Glen Banks is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of miniaturized dystrophins. His work has the potential to impact therapeutic approaches for various muscular disorders.
Latest Patents
Glen Banks holds a patent for "Miniaturized dystrophins having spectrin fusion domains and uses thereof." This patent discloses nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions related to miniaturized dystrophin. The methods of production and therapeutic use of the miniaturized dystrophin are also detailed in this patent. He has 1 patent to his name.
Career Highlights
Glen Banks is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His work at this leading pharmaceutical company allows him to collaborate with other experts in the field.
Collaborations
Some of his notable coworkers include Paul Charles Levesque and Jonathan Harry Davis. Their combined expertise contributes to the innovative environment at Bristol-Myers Squibb Company.
Conclusion
Glen Banks is a prominent figure in the field of biotechnology, with a focus on miniaturized dystrophins. His contributions and collaborations are paving the way for advancements in therapeutic applications.